Response to: “Immune checkpoint inhibitor-related Stevens-Johnson syndrome/toxic epidermal necrolysis-like reactions” - 08/07/21
Doi : 10.1016/j.jaad.2021.04.028
Gabriel E. Molina, MD a, Tracey S. Otto, MS a, b, Zizi Yu, BA a, c, Ruth K. Foreman, MD, PhD c, d, Kerry L. Reynolds, MD c, e, f, Steven T. Chen, MD, MPH, MS-HPEd a, c, e, ⁎ 
a Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts
b Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey
c Harvard Medical School, Boston, Massachusetts
d Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts
e Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
f Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts
∗Correspondence to: Steven T. Chen, MD, MPH, MS-HPEd, MGH Dermatology, Harvard Medical School, 50 Staniford Street, 2nd Floor, Boston, MA 02114MGH DermatologyHarvard Medical School50 Staniford Street, 2nd FloorBostonMA02114
Le texte complet de cet article est disponible en PDF.
| Authors Molina and Otto are cofirst authors. |
|
| Funding sources: None. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 85 - N° 2
P. e111-e112 - août 2021 Retour au numéro
Article précédent
- Immune checkpoint inhibitor-related Stevens-Johnson syndrome/toxic epidermal necrolysis-like reactions
- Ellie Ci-En Choi, Yee Kiat Heng, Yen Loo Lim
- From the Cochrane library: Teledermatology for diagnosing skin cancer in adults
- Torunn E. Sivesind, Mindy D. Szeto, Rubeta N. Matin, Robert P. Dellavalle
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?